Therapeutic Potential of Mitotic Kinases' Inhibitors in Cancers of the Gastrointestinal System
Mitosis entails mechanistic changes required for maintaining the genomic integrity in all dividing cells. The process is intricate and temporally and spatially regulated by the ordered series of activation and de-activation of protein kinases. The mitotic kinases ensure the stepwise progression of e...
Saved in:
Main Authors: | Aadil Javed (Author), Gianluca Malagraba (Author), Mahdieh Yarmohammadi (Author), Catalina M. Perelló-Reus (Author), Carles Barceló (Author), Teresa Rubio-Tomás (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors
by: Yooju Shin, et al.
Published: (2015) -
The silence of mitotic figures
by: Hope Haefner
Published: (2023) -
Serum and glucocorticoid-regulated kinase 1 (SGK1) as an emerging therapeutic target for cardiac diseases
by: Fatemeh Yarmohammadi, et al.
Published: (2024) -
Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
by: Rajashri R. Naik, et al.
Published: (2022) -
Piperine-Chlorogenic Acid Hybrid Inhibits the Proliferation of the SK-MEL-147 Melanoma Cells by Modulating Mitotic Kinases
by: Carolina Girotto Pressete, et al.
Published: (2023)